Therapeutic substituted indole compounds and compositions thereof
    2.
    发明授权
    Therapeutic substituted indole compounds and compositions thereof 失效
    治疗性取代的吲哚化合物及其组合物

    公开(公告)号:US5225431A

    公开(公告)日:1993-07-06

    申请号:US660966

    申请日:1991-02-26

    摘要: The present invention is concerned with compounds of formula (I) ##STR1## wherein R, R.sup.1 and R.sup.2 are independently selected from hydrogen and C.sub.1-4 alkyl;R.sup.3 and R.sup.4 are independently selected from hydrogen, C.sub.1-6 alkyl (including cycloalkyl) and aryl (wherein the alkyl or aryl group, which latter includes benzyl, is optionally substituted by one or more atoms or groups independently selected from halogen, C.sub.1-4 alkyl and aryl), provided R.sup.3 benzyl or substituted benzyl when R.sup.4 =H;m is an integer of from 0 to 2;n is an integer of from 0 to 3;(W) is a group of formula (i), (ii), (iii), or (iv) ##STR2## wherein Y is selected from oxygen, methylene and >N--R.sup.5, where R.sup.5 is hydrogen, C.sub.1-4 alkyl, or benzyl, Z and Z' are independently selected from >C.dbd.O, >C.dbd.S and methylene, and the chiral center * in formula (i) or (ii) is in its (S) or (R) form or is a mixture thereof in any proportions;X is a group selected fromaryl (including heteroaryl)xanthenyldibenzofuranyl which group is optionally substituted;and salts and solvates thereof, the preparation of these compounds, pharmaceutical formulations containing them and their use in medicine, particularly in the treatment of migraine.

    摘要翻译: 本发明涉及式(I)化合物:其中R 1,R 2和R 2独立地选自氢和C 1-4烷基; R 3和R 4独立地选自氢,C 1-6烷基(包括环烷基)和芳基(其中后者包括苄基的烷基或芳基任选被一个或多个独立地选自卤素,C 1-4的一个或多个原子或基团取代 烷基和芳基),当R 4 = H时提供R 3苄基或取代的苄基; m为0〜2的整数; n为0〜3的整数, (ⅰ)Y Y Y Y Y Y Y Y Y Y Y Y Y Y Y Y Y Y Y Y Y Y Y Y Y Y Y Y Y Y Y Y Y Y Y Y Y Y Y Y Y Y Y Y Y Y Y Y 选自氧,亚甲基和> N-R5,其中R5是氢,C1-4烷基或苄基,Z和Z'独立地选自C = O,> C = S和亚甲基,手性中心* 在式(ⅰ)或(ⅱ)中为其(S)或(R)形式或其任何比例的混合物; X是选自基团任选取代的芳基(包括杂芳基)呫吨基二苯并呋喃基的基团; 其盐和溶剂合物,这些化合物的制备,含有它们的药物制剂及其在医药中的用途,特别是用于治疗偏头痛。